Table 1.
Baseline characteristics (n = 43)
| Age (y) | 26 ± 5 |
| Male, n (%) | 18 (42) |
| Body mass index (kg/m2) | 26 ± 5 |
| Prior palliative shunt, n (%) | 43 (100) |
| Age at time of complete repair (y) | 4 (1-9) |
| Number of cardiac surgeries | 2 (2-4) |
| Number of conduit replacements, n (%) | |
| 1 | 22 (51) |
| 2 | 16 (37) |
| 3 | 5 (12) |
| RV-coronary artery fistula, n (%) | 9 (21) |
| RV-dependent coronary circulation | 0 |
| Comorbidities, n (%) | |
| Hypertension | 1 (2) |
| History of atrial fibrillation | 8 (19) |
| History of atrial flutter | 5 (12) |
| Laboratory Data | |
| NT proBNP (pg/mL) | 197 (109-641) |
| Haemoglobin (g/dL) | 13.2 ± 1.7 |
| Estimated GFR (mL/min/1.73 m2) | 81 ± 19 |
| Medications, n (%) | |
| Loop diuretics | 11 (26) |
| Beta-blockers | 7 (16) |
| ACEI/ARB | 5 (12) |
| Aldosterone antagonist | 6 (14) |
ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin II receptor blockers; GFR, glomerular filtration rate; NT proBNP, N-terminal pro-brain natriuretic peptide; RV, right ventricle.